Exclusive translation: A study of CTP-543 pills made by Concert Pharmaceuticals found that four out of 10 patients with alopecia areata were able to regrow nearly a full head of hair within half a year after taking the drug twice daily.
The mechanism of action of the property
However, the main scientist behind the drug does not expect it to work for the millions of men who lose their hair as they age.
The new treatment, made by the US drug company Concert Pharmaceuticals, works by inhibiting the immune response, preventing it from breaking down, according to the Daily Mail.
Time to put it on the market
Concert Pharma expects to apply for FDA approval for the drug next year after a phase II trial, which will repeat the study on 517 participants.
Approval is based on positive results from the second trial and may take up to 10 months.